M06.219 Rheumatoid bursitis, unspecified shoulder

Name of the Condition

• Rheumatoid bursitis, unspecified shoulder

Summary

Rheumatoid bursitis, unspecified shoulder is inflammation of the bursae (fluid-filled sacs that cushion joints) in the shoulder region, driven by rheumatoid arthritis (RA). This condition results from the immune system’s chronic inflammatory processes affecting the shoulder’s protective structures, leading to pain, swelling, and restricted mobility. Diagnosis requires correlation of clinical findings with RA history or serologic evidence.

Causes

Rheumatoid bursitis in the shoulder arises from the systemic inflammation of rheumatoid arthritis. The immune system’s attack on joint tissues extends to the shoulder’s bursae, causing fluid accumulation and irritation. While RA is the primary driver, mechanical stress or trauma to the shoulder may exacerbate inflammation in susceptible individuals.

Risk Factors

• Preexisting rheumatoid arthritis, increasing bursal inflammation risk.
• Advanced age, as RA severity often progresses over time.
• Prolonged shoulder overuse or pressure, which may irritate bursae.
• Systemic inflammation, as seen in active RA flares.

Symptoms

• Localized swelling and tenderness over the shoulder bursae.
• Pain with shoulder movement or pressure on the inflamed area.
• Reduced range of motion in the shoulder joint.
• Warmth or redness (if inflammation is acute).

Diagnosis

Diagnosis of rheumatoid bursitis, unspecified shoulder involves a combination of clinical evaluation and correlation with rheumatoid arthritis history. Physical examination may reveal swelling, tenderness, and limited shoulder mobility. Imaging (e.g., ultrasound or MRI) can assess bursal inflammation, while serologic tests (e.g., rheumatoid factor, anti-CCP antibodies) confirm RA. Exclusion of other shoulder conditions (e.g., infection, trauma) is essential.

Treatment Options

Treatment focuses on reducing inflammation and managing RA. Nonsteroidal anti-inflammatory drugs (NSAIDs) or corticosteroid injections may alleviate pain and swelling. Disease-modifying antirheumatic drugs (DMARDs) target underlying RA. Physical therapy improves mobility, while rest and activity modification reduce stress on the shoulder.

Prognosis and Follow-Up

Prognosis depends on RA control and adherence to treatment. With proper management, symptoms often improve, but chronic inflammation may lead to persistent discomfort. Regular follow-up monitors RA activity, adjusts therapy, and addresses complications. Long-term outcomes vary based on disease severity and response to treatment.

Complications

Untreated or poorly controlled inflammation may cause chronic pain, reduced shoulder function, or bursal thickening. Persistent inflammation increases the risk of secondary infections or adjacent tissue damage. RA progression can exacerbate bursal involvement, leading to more severe joint impairment.

Lifestyle & Prevention

Maintain RA control through prescribed medications and regular monitoring. Avoid repetitive shoulder motions or prolonged pressure. Use ergonomic supports during activities. Gentle exercises preserve mobility, while weight management reduces joint stress. Promptly address RA flares to minimize bursal inflammation.

When to Seek Professional Help

Seek care if shoulder pain worsens, swelling persists, or mobility declines. Immediate attention is needed for sudden severe pain, fever, or signs of infection (e.g., redness, warmth). Unexplained shoulder symptoms in RA patients require evaluation to rule out complications.

Tips for Medical Coders

Code M06.219 is specific to rheumatoid bursitis of the shoulder without specifying laterality. Documentation must confirm RA as the underlying cause and shoulder involvement. Ensure clinical notes support the diagnosis, including RA history, physical findings, or serologic evidence. Avoid using this code for non-RA-related bursitis or shoulder conditions.